¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"stem cell factor"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
cell culture
¼¼Æ÷¹è¾ç
cell cycle
¼¼Æ÷ÁÖ±â
cell death
¼¼Æ÷»ç
cell dedifferentiation
¼¼Æ÷Å»ºÐÈ
cell division
¼¼Æ÷ºÐ¿
cell envelope
¼¼Æ÷²®Áú, ¼¼Æ÷ÇǸ·
cell fusion
¼¼Æ÷À¶ÇÕ
cell inclusion
¼¼Æ÷Æ÷ÇÔ¹°, ¼¼Æ÷ºÀÀÔü
cell interaction
¼¼Æ÷»óÈ£ÀÛ¿ë
cell labeling technique
¼¼Æ÷Ç¥Áö±â¹ý
cell lethality
¼¼Æ÷Ä¡»çÀ²
cell line
¼¼Æ÷ÁÖ, ¼¼Æ÷°è
cell loss
¼¼Æ÷¼Ò½Ç
cell mass
¼¼Æ÷µ¢ÀÌ, ¼¼Æ÷±«
cell membrane
¼¼Æ÷¸·
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
cell-mediated cytotoxicity
¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º
cell-mediated hypersensitivity
¼¼Æ÷¸Å°³°ú¹Î
cell-mediated immunity
¼¼Æ÷¸Å°³¸é¿ª
cell-mediated reaction
¼¼Æ÷¸Å°³¹ÝÀÀ
cell-mediated response
¼¼Æ÷¸Å°³¹ÝÀÀ
cell-mediated immunodeficiency syndrome
¼¼Æ÷¸Å°³¸é¿ª°áÇÌÁõÈıº
cell-mediated lympholysis test
¼¼Æ÷¸Å°³¸²ÇÁ±¸¿ëÇØ½ÃÇè
centroacinar cell
»ù²Ê¸®Á߽ɼ¼Æ÷
chief cell
À¸¶ä¼¼Æ÷
Chinese hamster ovary cell
Áß±¹ºñ´ÜÅÐÁã³¼Ò¼¼Æ÷
chromaffin cell
ģũ·Ò¼¼Æ÷, Å©·Òģȼ¼Æ÷
chromophilic cell
»ö¼Òµë¼¼Æ÷, È£»ö¼Ò¼¼Æ÷
chromophobic cell
»ö¼Ò¾Èµë¼¼Æ÷
ciliated cell
¼¶¸ð¼¼Æ÷, ÀÜÅм¼Æ÷
clear cell
Åõ¸í¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
adcc(antibody dependent cell mediated cytotoxicity)
Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º(ù÷ô÷ëîðíá¬øàØÚË¿á¬øàÔ¸àõ)
adenoid basal cell carcinoma
¼±»ó(àÍßÒ) ±âÀú¼¼Æ÷¾Ï(Ðñî¼á¬øàäß)
adenoid squamous cell carcinoma
¼±»ó ÆíÆò »óÇǼ¼Æ÷(àÍßÒ ø·øÁ ß¾ù«á¬øà) ¾Ï
adult T Cell leukemia virus
¼ºÀÎ T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
adult T cell leukemia virus (HTLV)
¼ºÀÎT¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
adult t-cell leukemia/lymphoma
¼º¼÷ T-¼¼Æ÷ ¹éÇ÷º´/¸²ÇÁÁ¾(à÷âÙ¡á¬øà ÛÜúìÜ»/¡ðþ)
alpha cell
¾ËÆÄ¼¼Æ÷
alpha cell
¾ËÆÄ¼¼Æ÷(¡á¬øà)
alpha cell tumor
¾ËÆÄ ¼¼Æ÷Á¾(¡á¬øàðþ)
amacrine cell
¾Æ¸¶Å©¸° ¼¼Æ÷
amacrine cell
¹«Ãà»è¼¼Æ÷
ameboid cell
¾Æ¸Þ¹Ù¸ð¾ç¼¼Æ÷
aneuploid cell
À̼ö¼º¼¼Æ÷
anitschkow cell
¾Æ´ÏÄ¡ÄÚ¿ì¼¼Æ÷(¡á¬øà)
annular elastotic giant cell granuloma
ȯ»ó ź·Â ¼¶À¯¼º °Å´ë¼¼Æ÷ À°¾ÆÁ¾
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
factor x
Á¦10ÀÎÀÚ
factor xa
Á¦10 aÀÎÀÚ
factor xiia
Á¦12 aÀÎÀÚ
factor, chemotactic
ÈÇÐÁÖ¼ºÀÎÀÚ, ÁÖȼºÀÎÀÚ
factor, macrophage migration inhibition
´ë½Ä¼¼Æ÷ À¯ÁÖÀúÁöÀÎÀÚ
factor, tumor necrotizing(-sis) (TNF)
Á¾¾ç±«»çÀÎÀÚ
fermentation factor
¹ßÈ¿ÀÎÀÚ.
fibrin stabilizing factor
¼¶À¯¼Ò¾ÈÁ¤ÀÎÀÚ
fibrin stabilizing factor =FSF
¼¶À¯¼Ò¾ÈÁ¤ÀÎÀÚ(¡äÌïÒì×í), ¼¶À¯¼Ò¾ÈÁ¤ÀÎÀÚ.
fibrin-stabilizing factor
¼¶À¯¼Ò ¾ÈÁ¤ÀÎÀÚ, ¼¶À¯¼Ò¾ÈÁ¤ÀÎÀÚ.
fibroblast growth factor
¼¶À¯¸ð¼¼Æ÷ ¼ºÀåÀÎÀÚ(¡à÷íþì×í)
fibroblast growth factor(FGF)
¼¶À¯¾Æ¼¼Æ÷ ¼ºÀåÀÎÀÚ
genetic factor
À¯ÀüÀÎÀÚ(¡ì×í).
genetic factor
À¯ÀüÀÎÀÚ.
genetic factor
À¯ÀüÀÎÀÚ
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
16
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½